On this page:Overview Publications Researchers Institutions Open access

ScholarIQanswers from OpenAlex

Estudios Clínicos Latinoamérica

InstitutionResearch output, impact & collaborations

Estudios Clínicos Latinoamérica is a institution indexed in ScholarIQ from OpenAlex.

What is known about Estudios Clínicos Latinoamérica?

ScholarIQrecord summary

Estudios Clínicos Latinoamérica is a research organisation in Rosario, AR. OpenAlex records 1,730 works and 105,454 citations for it. 604 researchers list it as their most recent affiliation.

How many works does Estudios Clínicos Latinoamérica have?

ScholarIQindexed works

Estudios Clínicos Latinoamérica has 1,730 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

See the works listed for Estudios Clínicos Latinoamérica →

How many citations does Estudios Clínicos Latinoamérica have?

ScholarIQcitation count

Estudios Clínicos Latinoamérica has 105,454 citations in the OpenAlex counts ScholarIQ stores.

See the listed works for Estudios Clínicos Latinoamérica →

How many researchers are at Estudios Clínicos Latinoamérica?

ScholarIQresearcher count

Estudios Clínicos Latinoamérica has 604 researchers in the ScholarIQ index.

See the researchers listed on this page →

What is the average h-index at Estudios Clínicos Latinoamérica?

ScholarIQavg h-index

Estudios Clínicos Latinoamérica has an average h-index of 112 in OpenAlex.

Open the OpenAlex record →

What is the ROR of Estudios Clínicos Latinoamérica?

ScholarIQror

The ROR for Estudios Clínicos Latinoamérica is on the source record.

Open the ROR →

What is the OpenAlex record for Estudios Clínicos Latinoamérica?

ScholarIQopenalex

The OpenAlex for Estudios Clínicos Latinoamérica is on the source record.

Open the OpenAlex →

Who are the most-cited researchers behind Estudios Clínicos Latinoamérica?

ScholarIQtop researchers by citations

Rafael Díaz · Lipoproteins and Cardiovascular Health

381 works79,066 citations

What are the most-cited papers on Estudios Clínicos Latinoamérica?

ScholarIQmost cited works

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

Stuart J. Connolly, Michael D. Ezekowitz, Salim Yusuf, John W. Eikelboom, Jonas Oldgren, Amit Parekh, Janice Pogue, Paul Reilly, Ellison Themeles, Jeanne Varrone, Susan Wang, Marco Alings, Denis Xavier, Jun Zhu, Rafael Díaz, Basil S. Lewis, Harald Darius, Hans‐Christoph Diener, Campbell Joyner, Lars Wallentin

New England Journal of Medicine. 200911,232 CitationsOPEN ACCESS

Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome

Gregory G. Schwartz, Philippe Gabríel Steg, Michael Szarek, Deepak L. Bhatt, Vera Bittner, Rafael Díaz, Jay M. Edelberg, Shaun G. Goodman, Corinne Hanotin, Robert A. Harrington, J. Wouter Jukema, Guillaume Lecorps, Kenneth W. Mahaffey, Angèle Moryusef, Robert Pordy, Kirby Quintero, Matthew T. Roe, William J. Sasiela, Jean‐François Tamby, Pierluigi Tricoci, Harvey D. White, Andreas M. Zeiher

New England Journal of Medicine. 20183,564 CitationsOPEN ACCESS

Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction

Jean‐Claude Tardif, Simon Kouz, David D. Waters, Olivier F. Bertrand, Rafael Díaz, Aldo P. Maggioni, Fausto J. Pinto, Réda Ibrahim, Habib Gamra, Ghassan S. Kiwan, Colin Berry, José López‐Sendón, Petr Ošťádal, Wolfgang Köenig, Denis Angoulvant, Jean C. Grégoire, Marc-André Lavoie, Marie‐Pierre Dubé, David Rhainds, Mylène Provencher, Lucie Blondeau, Andreas Orfanos, Philippe L. L’Allier, Marie‐Claude Guertin, François Roubille

New England Journal of Medicine. 20193,029 CitationsOPEN ACCESS

Spironolactone for Heart Failure with Preserved Ejection Fraction

Bertram Pitt, Marc A. Pfeffer, Susan F. Assmann, Robin Boineau, Inder S. Anand, Brian Claggett, Nadine Clausell, Akshay S. Desai, Rafael Díaz, Jerome L. Fleg, И. Г. Гордеев, Brian Harty, John F. Heitner, Christopher T. Kenwood, Eldrin F. Lewis, Eileen O’Meara, Jeffrey L. Probstfield, Tamaz Shaburishvili, Sanjiv J. Shah, Scott D. Solomon, Nancy K. Sweitzer, Song Yang, Sonja M. McKinlay

New England Journal of Medicine. 20142,751 CitationsOPEN ACCESS

Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome

Marc A. Pfeffer, Brian Claggett, Rafael Díaz, Kenneth Dickstein, Hertzel C. Gerstein, Lars Køber, Francesca Lawson, Lin Ping, Xiaodan Wei, Eldrin F. Lewis, Aldo P. Maggioni, John J.V. McMurray, Jeffrey L. Probstfield, Matthew C. Riddle, Scott D. Solomon, Jean‐Claude Tardif

New England Journal of Medicine. 20152,360 CitationsOPEN ACCESS

How much of the research on Estudios Clínicos Latinoamérica is open access?

ScholarIQopen access share

83%OPEN ACCESS

Gold

Green

25%

Hybrid

Bronze

58%

Closed

17%